nodes	percent_of_prediction	percent_of_DWPC	metapath
Alfentanil—ALB—hematologic cancer	0.118	0.512	CbGaD
Alfentanil—ABCB1—hematologic cancer	0.112	0.488	CbGaD
Alfentanil—ORM1—Imatinib—hematologic cancer	0.0362	0.0654	CbGbCtD
Alfentanil—ABCB1—Lenalidomide—hematologic cancer	0.0178	0.0321	CbGbCtD
Alfentanil—CYP3A7—Ifosfamide—hematologic cancer	0.0171	0.0309	CbGbCtD
Alfentanil—CYP3A7-CYP3A51P—Ifosfamide—hematologic cancer	0.0171	0.0309	CbGbCtD
Alfentanil—CYP3A7—Imatinib—hematologic cancer	0.0163	0.0295	CbGbCtD
Alfentanil—CYP3A7-CYP3A51P—Imatinib—hematologic cancer	0.0163	0.0295	CbGbCtD
Alfentanil—CYP3A5—Daunorubicin—hematologic cancer	0.016	0.0289	CbGbCtD
Alfentanil—ALB—Imatinib—hematologic cancer	0.0152	0.0275	CbGbCtD
Alfentanil—CYP3A5—Thalidomide—hematologic cancer	0.0146	0.0263	CbGbCtD
Alfentanil—CYP3A5—Teniposide—hematologic cancer	0.0139	0.0251	CbGbCtD
Alfentanil—CYP3A5—Ifosfamide—hematologic cancer	0.0128	0.0232	CbGbCtD
Alfentanil—CYP3A5—Imatinib—hematologic cancer	0.0123	0.0221	CbGbCtD
Alfentanil—CYP3A4—Bexarotene—hematologic cancer	0.0106	0.0192	CbGbCtD
Alfentanil—ABCB1—Daunorubicin—hematologic cancer	0.0104	0.0188	CbGbCtD
Alfentanil—CYP3A7-CYP3A51P—Irinotecan—hematologic cancer	0.0102	0.0184	CbGbCtD
Alfentanil—CYP3A7—Irinotecan—hematologic cancer	0.0102	0.0184	CbGbCtD
Alfentanil—ABCB1—Alitretinoin—hematologic cancer	0.0102	0.0184	CbGbCtD
Alfentanil—ALB—Prednisone—hematologic cancer	0.01	0.0181	CbGbCtD
Alfentanil—CYP3A4—Busulfan—hematologic cancer	0.00989	0.0179	CbGbCtD
Alfentanil—CYP3A4—Lomustine—hematologic cancer	0.00989	0.0179	CbGbCtD
Alfentanil—CYP3A5—Dasatinib—hematologic cancer	0.00984	0.0178	CbGbCtD
Alfentanil—ALB—Irinotecan—hematologic cancer	0.00952	0.0172	CbGbCtD
Alfentanil—CYP3A7—Vincristine—hematologic cancer	0.00892	0.0161	CbGbCtD
Alfentanil—CYP3A7-CYP3A51P—Vincristine—hematologic cancer	0.00892	0.0161	CbGbCtD
Alfentanil—CYP3A4—Thiotepa—hematologic cancer	0.00882	0.0159	CbGbCtD
Alfentanil—ABCB1—Imatinib—hematologic cancer	0.00798	0.0144	CbGbCtD
Alfentanil—CYP3A5—Irinotecan—hematologic cancer	0.00765	0.0138	CbGbCtD
Alfentanil—ABCB1—Nilotinib—hematologic cancer	0.00725	0.0131	CbGbCtD
Alfentanil—ABCB1—Vinorelbine—hematologic cancer	0.00719	0.013	CbGbCtD
Alfentanil—CYP3A4—Methoxsalen—hematologic cancer	0.00686	0.0124	CbGbCtD
Alfentanil—CYP3A7-CYP3A51P—Dexamethasone—hematologic cancer	0.00672	0.0121	CbGbCtD
Alfentanil—CYP3A7—Dexamethasone—hematologic cancer	0.00672	0.0121	CbGbCtD
Alfentanil—CYP3A5—Vincristine—hematologic cancer	0.00669	0.0121	CbGbCtD
Alfentanil—CYP3A4—Bortezomib—hematologic cancer	0.00652	0.0118	CbGbCtD
Alfentanil—ABCB1—Dasatinib—hematologic cancer	0.00641	0.0116	CbGbCtD
Alfentanil—ABCB1—Mitoxantrone—hematologic cancer	0.00633	0.0114	CbGbCtD
Alfentanil—CYP3A4—Daunorubicin—hematologic cancer	0.00624	0.0113	CbGbCtD
Alfentanil—CYP3A5—Etoposide—hematologic cancer	0.00613	0.0111	CbGbCtD
Alfentanil—ABCB1—Betamethasone—hematologic cancer	0.00564	0.0102	CbGbCtD
Alfentanil—ABCB1—Gemcitabine—hematologic cancer	0.00559	0.0101	CbGbCtD
Alfentanil—ABCB1—Prednisolone—hematologic cancer	0.00556	0.01	CbGbCtD
Alfentanil—CYP3A4—Cytarabine—hematologic cancer	0.0055	0.00994	CbGbCtD
Alfentanil—CYP3A4—Teniposide—hematologic cancer	0.00542	0.00979	CbGbCtD
Alfentanil—ABCB1—Prednisone—hematologic cancer	0.00526	0.00949	CbGbCtD
Alfentanil—CYP3A5—Dexamethasone—hematologic cancer	0.00504	0.0091	CbGbCtD
Alfentanil—ALB—Methotrexate—hematologic cancer	0.00504	0.0091	CbGbCtD
Alfentanil—CYP3A4—Ifosfamide—hematologic cancer	0.005	0.00903	CbGbCtD
Alfentanil—ABCB1—Irinotecan—hematologic cancer	0.00498	0.00899	CbGbCtD
Alfentanil—CYP3A4—Imatinib—hematologic cancer	0.00478	0.00863	CbGbCtD
Alfentanil—CYP3A4—Ruxolitinib—hematologic cancer	0.0045	0.00812	CbGbCtD
Alfentanil—ABCB1—Vinblastine—hematologic cancer	0.00443	0.008	CbGbCtD
Alfentanil—ABCB1—Vincristine—hematologic cancer	0.00435	0.00786	CbGbCtD
Alfentanil—CYP3A4—Nilotinib—hematologic cancer	0.00434	0.00784	CbGbCtD
Alfentanil—CYP3A4—Vinorelbine—hematologic cancer	0.00431	0.00777	CbGbCtD
Alfentanil—ABCB1—Cisplatin—hematologic cancer	0.00406	0.00733	CbGbCtD
Alfentanil—ABCB1—Etoposide—hematologic cancer	0.00399	0.0072	CbGbCtD
Alfentanil—CYP3A4—Triamcinolone—hematologic cancer	0.00394	0.00711	CbGbCtD
Alfentanil—CYP3A4—Dasatinib—hematologic cancer	0.00384	0.00693	CbGbCtD
Alfentanil—CYP3A4—Mitoxantrone—hematologic cancer	0.00379	0.00684	CbGbCtD
Alfentanil—CYP3A4—Betamethasone—hematologic cancer	0.00338	0.0061	CbGbCtD
Alfentanil—CYP3A4—Prednisolone—hematologic cancer	0.00333	0.00602	CbGbCtD
Alfentanil—ABCB1—Dexamethasone—hematologic cancer	0.00328	0.00592	CbGbCtD
Alfentanil—CYP3A4—Prednisone—hematologic cancer	0.00315	0.00568	CbGbCtD
Alfentanil—CYP3A4—Irinotecan—hematologic cancer	0.00298	0.00539	CbGbCtD
Alfentanil—ABCB1—Doxorubicin—hematologic cancer	0.00272	0.00491	CbGbCtD
Alfentanil—CYP3A4—Vinblastine—hematologic cancer	0.00265	0.00479	CbGbCtD
Alfentanil—ABCB1—Methotrexate—hematologic cancer	0.00264	0.00476	CbGbCtD
Alfentanil—CYP3A4—Vincristine—hematologic cancer	0.00261	0.00471	CbGbCtD
Alfentanil—CYP3A4—Etoposide—hematologic cancer	0.00239	0.00432	CbGbCtD
Alfentanil—CYP3A4—Dexamethasone—hematologic cancer	0.00197	0.00355	CbGbCtD
Alfentanil—CYP3A4—Doxorubicin—hematologic cancer	0.00163	0.00294	CbGbCtD
Alfentanil—OPRM1—hematopoietic system—hematologic cancer	0.000137	0.106	CbGeAlD
Alfentanil—ORM1—hematopoietic system—hematologic cancer	0.000133	0.103	CbGeAlD
Alfentanil—OPRM1—blood—hematologic cancer	9.05e-05	0.0702	CbGeAlD
Alfentanil—ORM1—blood—hematologic cancer	8.83e-05	0.0685	CbGeAlD
Alfentanil—ORM1—bone marrow—hematologic cancer	8.55e-05	0.0663	CbGeAlD
Alfentanil—ORM1—lung—hematologic cancer	7.74e-05	0.0601	CbGeAlD
Alfentanil—OPRM1—testis—hematologic cancer	7.48e-05	0.0581	CbGeAlD
Alfentanil—CYP3A5—hematopoietic system—hematologic cancer	7.41e-05	0.0575	CbGeAlD
Alfentanil—ALB—testis—hematologic cancer	6.41e-05	0.0497	CbGeAlD
Alfentanil—Feeling abnormal—Prednisolone—hematologic cancer	5.69e-05	0.000325	CcSEcCtD
Alfentanil—Visual impairment—Methotrexate—hematologic cancer	5.69e-05	0.000324	CcSEcCtD
Alfentanil—Headache—Carmustine—hematologic cancer	5.67e-05	0.000324	CcSEcCtD
Alfentanil—Rash—Alitretinoin—hematologic cancer	5.66e-05	0.000323	CcSEcCtD
Alfentanil—Nervous system disorder—Dexamethasone—hematologic cancer	5.65e-05	0.000322	CcSEcCtD
Alfentanil—Nervous system disorder—Betamethasone—hematologic cancer	5.65e-05	0.000322	CcSEcCtD
Alfentanil—Agitation—Prednisone—hematologic cancer	5.65e-05	0.000322	CcSEcCtD
Alfentanil—Dermatitis—Alitretinoin—hematologic cancer	5.65e-05	0.000322	CcSEcCtD
Alfentanil—Vomiting—Ifosfamide—hematologic cancer	5.64e-05	0.000322	CcSEcCtD
Alfentanil—Hypersensitivity—Cisplatin—hematologic cancer	5.63e-05	0.000321	CcSEcCtD
Alfentanil—Tachycardia—Betamethasone—hematologic cancer	5.62e-05	0.000321	CcSEcCtD
Alfentanil—Tachycardia—Dexamethasone—hematologic cancer	5.62e-05	0.000321	CcSEcCtD
Alfentanil—Bradycardia—Epirubicin—hematologic cancer	5.62e-05	0.000321	CcSEcCtD
Alfentanil—Headache—Alitretinoin—hematologic cancer	5.62e-05	0.000321	CcSEcCtD
Alfentanil—Nausea—Thalidomide—hematologic cancer	5.6e-05	0.000319	CcSEcCtD
Alfentanil—Rash—Ifosfamide—hematologic cancer	5.59e-05	0.000319	CcSEcCtD
Alfentanil—Dermatitis—Ifosfamide—hematologic cancer	5.58e-05	0.000319	CcSEcCtD
Alfentanil—Hyperhidrosis—Dexamethasone—hematologic cancer	5.57e-05	0.000318	CcSEcCtD
Alfentanil—Hyperhidrosis—Betamethasone—hematologic cancer	5.57e-05	0.000318	CcSEcCtD
Alfentanil—Dizziness—Irinotecan—hematologic cancer	5.57e-05	0.000318	CcSEcCtD
Alfentanil—CYP3A4—hematopoietic system—hematologic cancer	5.56e-05	0.0432	CbGeAlD
Alfentanil—Urticaria—Etoposide—hematologic cancer	5.56e-05	0.000317	CcSEcCtD
Alfentanil—Body temperature increased—Etoposide—hematologic cancer	5.54e-05	0.000316	CcSEcCtD
Alfentanil—Eye disorder—Methotrexate—hematologic cancer	5.52e-05	0.000315	CcSEcCtD
Alfentanil—Vomiting—Vincristine—hematologic cancer	5.5e-05	0.000313	CcSEcCtD
Alfentanil—Urticaria—Prednisolone—hematologic cancer	5.49e-05	0.000313	CcSEcCtD
Alfentanil—Asthenia—Cisplatin—hematologic cancer	5.48e-05	0.000313	CcSEcCtD
Alfentanil—Cardiac disorder—Methotrexate—hematologic cancer	5.48e-05	0.000312	CcSEcCtD
Alfentanil—Fatigue—Triamcinolone—hematologic cancer	5.48e-05	0.000312	CcSEcCtD
Alfentanil—Rash—Vincristine—hematologic cancer	5.45e-05	0.000311	CcSEcCtD
Alfentanil—Dermatitis—Vincristine—hematologic cancer	5.44e-05	0.000311	CcSEcCtD
Alfentanil—Pain—Triamcinolone—hematologic cancer	5.43e-05	0.00031	CcSEcCtD
Alfentanil—Connective tissue disorder—Epirubicin—hematologic cancer	5.43e-05	0.00031	CcSEcCtD
Alfentanil—Headache—Vincristine—hematologic cancer	5.41e-05	0.000309	CcSEcCtD
Alfentanil—Loss of consciousness—Prednisone—hematologic cancer	5.4e-05	0.000308	CcSEcCtD
Alfentanil—Hypotension—Dexamethasone—hematologic cancer	5.38e-05	0.000307	CcSEcCtD
Alfentanil—Hypotension—Betamethasone—hematologic cancer	5.38e-05	0.000307	CcSEcCtD
Alfentanil—Nausea—Carmustine—hematologic cancer	5.38e-05	0.000307	CcSEcCtD
Alfentanil—Epistaxis—Doxorubicin—hematologic cancer	5.37e-05	0.000306	CcSEcCtD
Alfentanil—Angiopathy—Methotrexate—hematologic cancer	5.36e-05	0.000305	CcSEcCtD
Alfentanil—Vomiting—Mitoxantrone—hematologic cancer	5.35e-05	0.000305	CcSEcCtD
Alfentanil—Vomiting—Irinotecan—hematologic cancer	5.35e-05	0.000305	CcSEcCtD
Alfentanil—Immune system disorder—Methotrexate—hematologic cancer	5.33e-05	0.000304	CcSEcCtD
Alfentanil—Nausea—Alitretinoin—hematologic cancer	5.33e-05	0.000304	CcSEcCtD
Alfentanil—Convulsion—Prednisone—hematologic cancer	5.33e-05	0.000304	CcSEcCtD
Alfentanil—Visual impairment—Epirubicin—hematologic cancer	5.32e-05	0.000304	CcSEcCtD
Alfentanil—Mediastinal disorder—Methotrexate—hematologic cancer	5.32e-05	0.000303	CcSEcCtD
Alfentanil—Hypertension—Prednisone—hematologic cancer	5.31e-05	0.000303	CcSEcCtD
Alfentanil—Rash—Irinotecan—hematologic cancer	5.31e-05	0.000303	CcSEcCtD
Alfentanil—Rash—Mitoxantrone—hematologic cancer	5.31e-05	0.000303	CcSEcCtD
Alfentanil—Dermatitis—Irinotecan—hematologic cancer	5.3e-05	0.000302	CcSEcCtD
Alfentanil—Dermatitis—Mitoxantrone—hematologic cancer	5.3e-05	0.000302	CcSEcCtD
Alfentanil—Chills—Methotrexate—hematologic cancer	5.3e-05	0.000302	CcSEcCtD
Alfentanil—ORM1—lymph node—hematologic cancer	5.3e-05	0.0411	CbGeAlD
Alfentanil—Headache—Mitoxantrone—hematologic cancer	5.27e-05	0.000301	CcSEcCtD
Alfentanil—Headache—Irinotecan—hematologic cancer	5.27e-05	0.000301	CcSEcCtD
Alfentanil—Nausea—Ifosfamide—hematologic cancer	5.27e-05	0.0003	CcSEcCtD
Alfentanil—Feeling abnormal—Triamcinolone—hematologic cancer	5.23e-05	0.000299	CcSEcCtD
Alfentanil—Vomiting—Gemcitabine—hematologic cancer	5.21e-05	0.000297	CcSEcCtD
Alfentanil—Bradycardia—Doxorubicin—hematologic cancer	5.2e-05	0.000297	CcSEcCtD
Alfentanil—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	5.2e-05	0.000297	CcSEcCtD
Alfentanil—Mental disorder—Methotrexate—hematologic cancer	5.17e-05	0.000295	CcSEcCtD
Alfentanil—Rash—Gemcitabine—hematologic cancer	5.17e-05	0.000295	CcSEcCtD
Alfentanil—Dermatitis—Gemcitabine—hematologic cancer	5.17e-05	0.000295	CcSEcCtD
Alfentanil—Eye disorder—Epirubicin—hematologic cancer	5.16e-05	0.000294	CcSEcCtD
Alfentanil—Hypersensitivity—Etoposide—hematologic cancer	5.16e-05	0.000294	CcSEcCtD
Alfentanil—Erythema—Methotrexate—hematologic cancer	5.14e-05	0.000293	CcSEcCtD
Alfentanil—Headache—Gemcitabine—hematologic cancer	5.14e-05	0.000293	CcSEcCtD
Alfentanil—Nausea—Vincristine—hematologic cancer	5.13e-05	0.000293	CcSEcCtD
Alfentanil—Cardiac disorder—Epirubicin—hematologic cancer	5.13e-05	0.000292	CcSEcCtD
Alfentanil—Hypersensitivity—Prednisolone—hematologic cancer	5.09e-05	0.00029	CcSEcCtD
Alfentanil—Urticaria—Triamcinolone—hematologic cancer	5.05e-05	0.000288	CcSEcCtD
Alfentanil—Asthenia—Etoposide—hematologic cancer	5.02e-05	0.000287	CcSEcCtD
Alfentanil—Connective tissue disorder—Doxorubicin—hematologic cancer	5.02e-05	0.000287	CcSEcCtD
Alfentanil—Body temperature increased—Triamcinolone—hematologic cancer	5.02e-05	0.000286	CcSEcCtD
Alfentanil—Anaphylactic shock—Prednisone—hematologic cancer	5.02e-05	0.000286	CcSEcCtD
Alfentanil—Angiopathy—Epirubicin—hematologic cancer	5.01e-05	0.000286	CcSEcCtD
Alfentanil—Nausea—Irinotecan—hematologic cancer	5e-05	0.000285	CcSEcCtD
Alfentanil—Nausea—Mitoxantrone—hematologic cancer	5e-05	0.000285	CcSEcCtD
Alfentanil—Immune system disorder—Epirubicin—hematologic cancer	4.99e-05	0.000285	CcSEcCtD
Alfentanil—Mediastinal disorder—Epirubicin—hematologic cancer	4.98e-05	0.000284	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Betamethasone—hematologic cancer	4.98e-05	0.000284	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Dexamethasone—hematologic cancer	4.98e-05	0.000284	CcSEcCtD
Alfentanil—Fatigue—Dexamethasone—hematologic cancer	4.97e-05	0.000283	CcSEcCtD
Alfentanil—Fatigue—Betamethasone—hematologic cancer	4.97e-05	0.000283	CcSEcCtD
Alfentanil—Chills—Epirubicin—hematologic cancer	4.96e-05	0.000283	CcSEcCtD
Alfentanil—Pruritus—Etoposide—hematologic cancer	4.95e-05	0.000283	CcSEcCtD
Alfentanil—Arrhythmia—Epirubicin—hematologic cancer	4.94e-05	0.000281	CcSEcCtD
Alfentanil—Pain—Dexamethasone—hematologic cancer	4.93e-05	0.000281	CcSEcCtD
Alfentanil—Pain—Betamethasone—hematologic cancer	4.93e-05	0.000281	CcSEcCtD
Alfentanil—Visual impairment—Doxorubicin—hematologic cancer	4.93e-05	0.000281	CcSEcCtD
Alfentanil—Nervous system disorder—Prednisone—hematologic cancer	4.92e-05	0.000281	CcSEcCtD
Alfentanil—CYP3A5—blood—hematologic cancer	4.91e-05	0.0381	CbGeAlD
Alfentanil—Tachycardia—Prednisone—hematologic cancer	4.9e-05	0.000279	CcSEcCtD
Alfentanil—Skin disorder—Prednisone—hematologic cancer	4.87e-05	0.000278	CcSEcCtD
Alfentanil—Nausea—Gemcitabine—hematologic cancer	4.87e-05	0.000278	CcSEcCtD
Alfentanil—Vomiting—Cisplatin—hematologic cancer	4.86e-05	0.000277	CcSEcCtD
Alfentanil—Hyperhidrosis—Prednisone—hematologic cancer	4.85e-05	0.000277	CcSEcCtD
Alfentanil—Vision blurred—Methotrexate—hematologic cancer	4.84e-05	0.000276	CcSEcCtD
Alfentanil—Mental disorder—Epirubicin—hematologic cancer	4.84e-05	0.000276	CcSEcCtD
Alfentanil—Rash—Cisplatin—hematologic cancer	4.82e-05	0.000275	CcSEcCtD
Alfentanil—Dermatitis—Cisplatin—hematologic cancer	4.81e-05	0.000275	CcSEcCtD
Alfentanil—Erythema—Epirubicin—hematologic cancer	4.81e-05	0.000274	CcSEcCtD
Alfentanil—Eye disorder—Doxorubicin—hematologic cancer	4.78e-05	0.000272	CcSEcCtD
Alfentanil—Feeling abnormal—Betamethasone—hematologic cancer	4.75e-05	0.000271	CcSEcCtD
Alfentanil—Feeling abnormal—Dexamethasone—hematologic cancer	4.75e-05	0.000271	CcSEcCtD
Alfentanil—Cardiac disorder—Doxorubicin—hematologic cancer	4.74e-05	0.000271	CcSEcCtD
Alfentanil—Hypersensitivity—Triamcinolone—hematologic cancer	4.68e-05	0.000267	CcSEcCtD
Alfentanil—ALB—lymph node—hematologic cancer	4.64e-05	0.036	CbGeAlD
Alfentanil—Angiopathy—Doxorubicin—hematologic cancer	4.64e-05	0.000265	CcSEcCtD
Alfentanil—Dizziness—Etoposide—hematologic cancer	4.63e-05	0.000264	CcSEcCtD
Alfentanil—Immune system disorder—Doxorubicin—hematologic cancer	4.62e-05	0.000263	CcSEcCtD
Alfentanil—Mediastinal disorder—Doxorubicin—hematologic cancer	4.61e-05	0.000263	CcSEcCtD
Alfentanil—Chills—Doxorubicin—hematologic cancer	4.59e-05	0.000262	CcSEcCtD
Alfentanil—Urticaria—Dexamethasone—hematologic cancer	4.58e-05	0.000261	CcSEcCtD
Alfentanil—Urticaria—Betamethasone—hematologic cancer	4.58e-05	0.000261	CcSEcCtD
Alfentanil—Dizziness—Prednisolone—hematologic cancer	4.57e-05	0.00026	CcSEcCtD
Alfentanil—Arrhythmia—Doxorubicin—hematologic cancer	4.57e-05	0.00026	CcSEcCtD
Alfentanil—Asthenia—Triamcinolone—hematologic cancer	4.56e-05	0.00026	CcSEcCtD
Alfentanil—Body temperature increased—Betamethasone—hematologic cancer	4.56e-05	0.00026	CcSEcCtD
Alfentanil—Body temperature increased—Dexamethasone—hematologic cancer	4.56e-05	0.00026	CcSEcCtD
Alfentanil—Nausea—Cisplatin—hematologic cancer	4.54e-05	0.000259	CcSEcCtD
Alfentanil—Vision blurred—Epirubicin—hematologic cancer	4.53e-05	0.000259	CcSEcCtD
Alfentanil—Pruritus—Triamcinolone—hematologic cancer	4.49e-05	0.000256	CcSEcCtD
Alfentanil—Cough—Methotrexate—hematologic cancer	4.48e-05	0.000256	CcSEcCtD
Alfentanil—Mental disorder—Doxorubicin—hematologic cancer	4.48e-05	0.000255	CcSEcCtD
Alfentanil—Convulsion—Methotrexate—hematologic cancer	4.45e-05	0.000254	CcSEcCtD
Alfentanil—Vomiting—Etoposide—hematologic cancer	4.45e-05	0.000254	CcSEcCtD
Alfentanil—Erythema—Doxorubicin—hematologic cancer	4.45e-05	0.000254	CcSEcCtD
Alfentanil—Agitation—Epirubicin—hematologic cancer	4.42e-05	0.000252	CcSEcCtD
Alfentanil—Rash—Etoposide—hematologic cancer	4.41e-05	0.000252	CcSEcCtD
Alfentanil—Dermatitis—Etoposide—hematologic cancer	4.41e-05	0.000252	CcSEcCtD
Alfentanil—Headache—Etoposide—hematologic cancer	4.39e-05	0.00025	CcSEcCtD
Alfentanil—Rash—Prednisolone—hematologic cancer	4.35e-05	0.000248	CcSEcCtD
Alfentanil—Dermatitis—Prednisolone—hematologic cancer	4.35e-05	0.000248	CcSEcCtD
Alfentanil—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	4.34e-05	0.000248	CcSEcCtD
Alfentanil—Fatigue—Prednisone—hematologic cancer	4.33e-05	0.000247	CcSEcCtD
Alfentanil—Headache—Prednisolone—hematologic cancer	4.33e-05	0.000247	CcSEcCtD
Alfentanil—CYP3A5—lung—hematologic cancer	4.31e-05	0.0334	CbGeAlD
Alfentanil—Confusional state—Methotrexate—hematologic cancer	4.23e-05	0.000241	CcSEcCtD
Alfentanil—Loss of consciousness—Epirubicin—hematologic cancer	4.23e-05	0.000241	CcSEcCtD
Alfentanil—Dizziness—Triamcinolone—hematologic cancer	4.2e-05	0.00024	CcSEcCtD
Alfentanil—Cough—Epirubicin—hematologic cancer	4.2e-05	0.000239	CcSEcCtD
Alfentanil—Anaphylactic shock—Methotrexate—hematologic cancer	4.19e-05	0.000239	CcSEcCtD
Alfentanil—Vision blurred—Doxorubicin—hematologic cancer	4.19e-05	0.000239	CcSEcCtD
Alfentanil—Convulsion—Epirubicin—hematologic cancer	4.17e-05	0.000238	CcSEcCtD
Alfentanil—Nausea—Etoposide—hematologic cancer	4.16e-05	0.000237	CcSEcCtD
Alfentanil—Hypertension—Epirubicin—hematologic cancer	4.15e-05	0.000237	CcSEcCtD
Alfentanil—Feeling abnormal—Prednisone—hematologic cancer	4.14e-05	0.000236	CcSEcCtD
Alfentanil—Asthenia—Betamethasone—hematologic cancer	4.13e-05	0.000236	CcSEcCtD
Alfentanil—Asthenia—Dexamethasone—hematologic cancer	4.13e-05	0.000236	CcSEcCtD
Alfentanil—Nervous system disorder—Methotrexate—hematologic cancer	4.11e-05	0.000235	CcSEcCtD
Alfentanil—Nausea—Prednisolone—hematologic cancer	4.1e-05	0.000234	CcSEcCtD
Alfentanil—Agitation—Doxorubicin—hematologic cancer	4.09e-05	0.000233	CcSEcCtD
Alfentanil—Pruritus—Betamethasone—hematologic cancer	4.08e-05	0.000233	CcSEcCtD
Alfentanil—Pruritus—Dexamethasone—hematologic cancer	4.08e-05	0.000233	CcSEcCtD
Alfentanil—Skin disorder—Methotrexate—hematologic cancer	4.07e-05	0.000232	CcSEcCtD
Alfentanil—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	4.07e-05	0.000232	CcSEcCtD
Alfentanil—Hyperhidrosis—Methotrexate—hematologic cancer	4.05e-05	0.000231	CcSEcCtD
Alfentanil—Vomiting—Triamcinolone—hematologic cancer	4.04e-05	0.00023	CcSEcCtD
Alfentanil—Rash—Triamcinolone—hematologic cancer	4e-05	0.000228	CcSEcCtD
Alfentanil—Dermatitis—Triamcinolone—hematologic cancer	4e-05	0.000228	CcSEcCtD
Alfentanil—Urticaria—Prednisone—hematologic cancer	3.99e-05	0.000227	CcSEcCtD
Alfentanil—Headache—Triamcinolone—hematologic cancer	3.98e-05	0.000227	CcSEcCtD
Alfentanil—Body temperature increased—Prednisone—hematologic cancer	3.97e-05	0.000226	CcSEcCtD
Alfentanil—Confusional state—Epirubicin—hematologic cancer	3.96e-05	0.000226	CcSEcCtD
Alfentanil—ABCB1—hematopoietic system—hematologic cancer	3.94e-05	0.0306	CbGeAlD
Alfentanil—Anaphylactic shock—Epirubicin—hematologic cancer	3.92e-05	0.000224	CcSEcCtD
Alfentanil—Hypotension—Methotrexate—hematologic cancer	3.92e-05	0.000224	CcSEcCtD
Alfentanil—Loss of consciousness—Doxorubicin—hematologic cancer	3.91e-05	0.000223	CcSEcCtD
Alfentanil—Cough—Doxorubicin—hematologic cancer	3.88e-05	0.000221	CcSEcCtD
Alfentanil—Convulsion—Doxorubicin—hematologic cancer	3.86e-05	0.00022	CcSEcCtD
Alfentanil—Nervous system disorder—Epirubicin—hematologic cancer	3.85e-05	0.00022	CcSEcCtD
Alfentanil—Hypertension—Doxorubicin—hematologic cancer	3.84e-05	0.000219	CcSEcCtD
Alfentanil—Tachycardia—Epirubicin—hematologic cancer	3.83e-05	0.000218	CcSEcCtD
Alfentanil—Skin disorder—Epirubicin—hematologic cancer	3.81e-05	0.000217	CcSEcCtD
Alfentanil—Dizziness—Dexamethasone—hematologic cancer	3.81e-05	0.000217	CcSEcCtD
Alfentanil—Dizziness—Betamethasone—hematologic cancer	3.81e-05	0.000217	CcSEcCtD
Alfentanil—Hyperhidrosis—Epirubicin—hematologic cancer	3.79e-05	0.000216	CcSEcCtD
Alfentanil—Nausea—Triamcinolone—hematologic cancer	3.77e-05	0.000215	CcSEcCtD
Alfentanil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	3.76e-05	0.000215	CcSEcCtD
Alfentanil—Somnolence—Methotrexate—hematologic cancer	3.73e-05	0.000213	CcSEcCtD
Alfentanil—Hypersensitivity—Prednisone—hematologic cancer	3.7e-05	0.000211	CcSEcCtD
Alfentanil—CYP3A4—blood—hematologic cancer	3.69e-05	0.0286	CbGeAlD
Alfentanil—Hypotension—Epirubicin—hematologic cancer	3.67e-05	0.000209	CcSEcCtD
Alfentanil—Vomiting—Dexamethasone—hematologic cancer	3.66e-05	0.000209	CcSEcCtD
Alfentanil—Vomiting—Betamethasone—hematologic cancer	3.66e-05	0.000209	CcSEcCtD
Alfentanil—Confusional state—Doxorubicin—hematologic cancer	3.66e-05	0.000209	CcSEcCtD
Alfentanil—Rash—Dexamethasone—hematologic cancer	3.63e-05	0.000207	CcSEcCtD
Alfentanil—Rash—Betamethasone—hematologic cancer	3.63e-05	0.000207	CcSEcCtD
Alfentanil—Anaphylactic shock—Doxorubicin—hematologic cancer	3.63e-05	0.000207	CcSEcCtD
Alfentanil—Dermatitis—Betamethasone—hematologic cancer	3.63e-05	0.000207	CcSEcCtD
Alfentanil—Dermatitis—Dexamethasone—hematologic cancer	3.63e-05	0.000207	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Methotrexate—hematologic cancer	3.62e-05	0.000207	CcSEcCtD
Alfentanil—Fatigue—Methotrexate—hematologic cancer	3.62e-05	0.000206	CcSEcCtD
Alfentanil—Headache—Dexamethasone—hematologic cancer	3.61e-05	0.000206	CcSEcCtD
Alfentanil—Headache—Betamethasone—hematologic cancer	3.61e-05	0.000206	CcSEcCtD
Alfentanil—Asthenia—Prednisone—hematologic cancer	3.6e-05	0.000205	CcSEcCtD
Alfentanil—Pain—Methotrexate—hematologic cancer	3.59e-05	0.000205	CcSEcCtD
Alfentanil—Nervous system disorder—Doxorubicin—hematologic cancer	3.56e-05	0.000203	CcSEcCtD
Alfentanil—Pruritus—Prednisone—hematologic cancer	3.55e-05	0.000203	CcSEcCtD
Alfentanil—Tachycardia—Doxorubicin—hematologic cancer	3.54e-05	0.000202	CcSEcCtD
Alfentanil—Skin disorder—Doxorubicin—hematologic cancer	3.53e-05	0.000201	CcSEcCtD
Alfentanil—Hyperhidrosis—Doxorubicin—hematologic cancer	3.51e-05	0.0002	CcSEcCtD
Alfentanil—Somnolence—Epirubicin—hematologic cancer	3.49e-05	0.000199	CcSEcCtD
Alfentanil—Feeling abnormal—Methotrexate—hematologic cancer	3.46e-05	0.000197	CcSEcCtD
Alfentanil—Nausea—Betamethasone—hematologic cancer	3.42e-05	0.000195	CcSEcCtD
Alfentanil—Nausea—Dexamethasone—hematologic cancer	3.42e-05	0.000195	CcSEcCtD
Alfentanil—Hypotension—Doxorubicin—hematologic cancer	3.39e-05	0.000194	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Epirubicin—hematologic cancer	3.39e-05	0.000193	CcSEcCtD
Alfentanil—Fatigue—Epirubicin—hematologic cancer	3.38e-05	0.000193	CcSEcCtD
Alfentanil—Pain—Epirubicin—hematologic cancer	3.36e-05	0.000191	CcSEcCtD
Alfentanil—Urticaria—Methotrexate—hematologic cancer	3.33e-05	0.00019	CcSEcCtD
Alfentanil—Dizziness—Prednisone—hematologic cancer	3.32e-05	0.000189	CcSEcCtD
Alfentanil—Body temperature increased—Methotrexate—hematologic cancer	3.32e-05	0.000189	CcSEcCtD
Alfentanil—Feeling abnormal—Epirubicin—hematologic cancer	3.23e-05	0.000184	CcSEcCtD
Alfentanil—Somnolence—Doxorubicin—hematologic cancer	3.23e-05	0.000184	CcSEcCtD
Alfentanil—Vomiting—Prednisone—hematologic cancer	3.19e-05	0.000182	CcSEcCtD
Alfentanil—Rash—Prednisone—hematologic cancer	3.16e-05	0.00018	CcSEcCtD
Alfentanil—Dermatitis—Prednisone—hematologic cancer	3.16e-05	0.00018	CcSEcCtD
Alfentanil—Headache—Prednisone—hematologic cancer	3.14e-05	0.000179	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Doxorubicin—hematologic cancer	3.14e-05	0.000179	CcSEcCtD
Alfentanil—Fatigue—Doxorubicin—hematologic cancer	3.13e-05	0.000179	CcSEcCtD
Alfentanil—Urticaria—Epirubicin—hematologic cancer	3.12e-05	0.000178	CcSEcCtD
Alfentanil—Pain—Doxorubicin—hematologic cancer	3.11e-05	0.000177	CcSEcCtD
Alfentanil—Body temperature increased—Epirubicin—hematologic cancer	3.1e-05	0.000177	CcSEcCtD
Alfentanil—Hypersensitivity—Methotrexate—hematologic cancer	3.09e-05	0.000176	CcSEcCtD
Alfentanil—Asthenia—Methotrexate—hematologic cancer	3.01e-05	0.000172	CcSEcCtD
Alfentanil—ABCB1—gonad—hematologic cancer	2.99e-05	0.0232	CbGeAlD
Alfentanil—Feeling abnormal—Doxorubicin—hematologic cancer	2.99e-05	0.000171	CcSEcCtD
Alfentanil—Nausea—Prednisone—hematologic cancer	2.98e-05	0.00017	CcSEcCtD
Alfentanil—Pruritus—Methotrexate—hematologic cancer	2.97e-05	0.000169	CcSEcCtD
Alfentanil—Hypersensitivity—Epirubicin—hematologic cancer	2.89e-05	0.000165	CcSEcCtD
Alfentanil—Urticaria—Doxorubicin—hematologic cancer	2.89e-05	0.000165	CcSEcCtD
Alfentanil—Body temperature increased—Doxorubicin—hematologic cancer	2.87e-05	0.000164	CcSEcCtD
Alfentanil—Asthenia—Epirubicin—hematologic cancer	2.82e-05	0.000161	CcSEcCtD
Alfentanil—Pruritus—Epirubicin—hematologic cancer	2.78e-05	0.000158	CcSEcCtD
Alfentanil—Dizziness—Methotrexate—hematologic cancer	2.77e-05	0.000158	CcSEcCtD
Alfentanil—Hypersensitivity—Doxorubicin—hematologic cancer	2.68e-05	0.000153	CcSEcCtD
Alfentanil—Vomiting—Methotrexate—hematologic cancer	2.67e-05	0.000152	CcSEcCtD
Alfentanil—Rash—Methotrexate—hematologic cancer	2.64e-05	0.000151	CcSEcCtD
Alfentanil—Dermatitis—Methotrexate—hematologic cancer	2.64e-05	0.000151	CcSEcCtD
Alfentanil—Headache—Methotrexate—hematologic cancer	2.63e-05	0.00015	CcSEcCtD
Alfentanil—ABCB1—blood—hematologic cancer	2.61e-05	0.0202	CbGeAlD
Alfentanil—Asthenia—Doxorubicin—hematologic cancer	2.61e-05	0.000149	CcSEcCtD
Alfentanil—Dizziness—Epirubicin—hematologic cancer	2.6e-05	0.000148	CcSEcCtD
Alfentanil—Pruritus—Doxorubicin—hematologic cancer	2.57e-05	0.000147	CcSEcCtD
Alfentanil—ABCB1—bone marrow—hematologic cancer	2.52e-05	0.0196	CbGeAlD
Alfentanil—Vomiting—Epirubicin—hematologic cancer	2.5e-05	0.000142	CcSEcCtD
Alfentanil—Nausea—Methotrexate—hematologic cancer	2.49e-05	0.000142	CcSEcCtD
Alfentanil—Rash—Epirubicin—hematologic cancer	2.47e-05	0.000141	CcSEcCtD
Alfentanil—Dermatitis—Epirubicin—hematologic cancer	2.47e-05	0.000141	CcSEcCtD
Alfentanil—Headache—Epirubicin—hematologic cancer	2.46e-05	0.00014	CcSEcCtD
Alfentanil—Dizziness—Doxorubicin—hematologic cancer	2.4e-05	0.000137	CcSEcCtD
Alfentanil—Nausea—Epirubicin—hematologic cancer	2.33e-05	0.000133	CcSEcCtD
Alfentanil—Vomiting—Doxorubicin—hematologic cancer	2.31e-05	0.000132	CcSEcCtD
Alfentanil—Rash—Doxorubicin—hematologic cancer	2.29e-05	0.000131	CcSEcCtD
Alfentanil—Dermatitis—Doxorubicin—hematologic cancer	2.29e-05	0.00013	CcSEcCtD
Alfentanil—ABCB1—lung—hematologic cancer	2.29e-05	0.0177	CbGeAlD
Alfentanil—Headache—Doxorubicin—hematologic cancer	2.28e-05	0.00013	CcSEcCtD
Alfentanil—ABCB1—testis—hematologic cancer	2.16e-05	0.0167	CbGeAlD
Alfentanil—Nausea—Doxorubicin—hematologic cancer	2.16e-05	0.000123	CcSEcCtD
Alfentanil—ABCB1—lymph node—hematologic cancer	1.56e-05	0.0121	CbGeAlD
Alfentanil—OPRM1—Signaling Pathways—PDGFA—hematologic cancer	6.77e-06	0.000171	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—KITLG—hematologic cancer	6.67e-06	0.000168	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—CREBBP—hematologic cancer	6.67e-06	0.000168	CbGpPWpGaD
Alfentanil—ALB—Metabolism—ADCY7—hematologic cancer	6.66e-06	0.000168	CbGpPWpGaD
Alfentanil—ALB—Metabolism—NCOA3—hematologic cancer	6.66e-06	0.000168	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—SLC35B2—hematologic cancer	6.66e-06	0.000168	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—GBA—hematologic cancer	6.66e-06	0.000168	CbGpPWpGaD
Alfentanil—ALB—Metabolism—NUP214—hematologic cancer	6.61e-06	0.000167	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—UGT1A1—hematologic cancer	6.55e-06	0.000165	CbGpPWpGaD
Alfentanil—ALB—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	6.55e-06	0.000165	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—STAT5A—hematologic cancer	6.52e-06	0.000164	CbGpPWpGaD
Alfentanil—ALB—Platelet activation, signaling and aggregation—PIK3CA—hematologic cancer	6.52e-06	0.000164	CbGpPWpGaD
Alfentanil—OPRM1—GPCR downstream signaling—PIK3CB—hematologic cancer	6.5e-06	0.000164	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—ABCB1—hematologic cancer	6.5e-06	0.000164	CbGpPWpGaD
Alfentanil—ALB—Metabolism—MTR—hematologic cancer	6.48e-06	0.000163	CbGpPWpGaD
Alfentanil—ALB—Metabolism—ABCG2—hematologic cancer	6.48e-06	0.000163	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—CDKN2B—hematologic cancer	6.46e-06	0.000163	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	6.42e-06	0.000162	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—PIK3R1—hematologic cancer	6.4e-06	0.000161	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—SLC22A1—hematologic cancer	6.37e-06	0.000161	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—CRABP1—hematologic cancer	6.37e-06	0.000161	CbGpPWpGaD
Alfentanil—ALB—Metabolism—ENO2—hematologic cancer	6.35e-06	0.00016	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—PIK3CD—hematologic cancer	6.32e-06	0.000159	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—GSTM1—hematologic cancer	6.31e-06	0.000159	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—NCOR1—hematologic cancer	6.31e-06	0.000159	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—CD86—hematologic cancer	6.25e-06	0.000158	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—JAK2—hematologic cancer	6.22e-06	0.000157	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—ALOX5—hematologic cancer	6.21e-06	0.000157	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	6.21e-06	0.000157	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—HES1—hematologic cancer	6.17e-06	0.000156	CbGpPWpGaD
Alfentanil—ALB—Metabolism—GSTT1—hematologic cancer	6.16e-06	0.000155	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—NCOR1—hematologic cancer	6.13e-06	0.000155	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—MTAP—hematologic cancer	6.09e-06	0.000154	CbGpPWpGaD
Alfentanil—ALB—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	6.07e-06	0.000153	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—FGF1—hematologic cancer	6.06e-06	0.000153	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—CSF2—hematologic cancer	6.06e-06	0.000153	CbGpPWpGaD
Alfentanil—ALB—Metabolism—SDC1—hematologic cancer	6.02e-06	0.000152	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—NUP98—hematologic cancer	6.01e-06	0.000152	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—FOXO1—hematologic cancer	5.97e-06	0.000151	CbGpPWpGaD
Alfentanil—OPRM1—GPCR downstream signaling—IL2—hematologic cancer	5.97e-06	0.000151	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—PIK3R1—hematologic cancer	5.97e-06	0.000151	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—PDGFRB—hematologic cancer	5.96e-06	0.00015	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—NQO1—hematologic cancer	5.95e-06	0.00015	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—CD44—hematologic cancer	5.95e-06	0.00015	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—PIK3CB—hematologic cancer	5.9e-06	0.000149	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—PDGFRA—hematologic cancer	5.87e-06	0.000148	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—JAK1—hematologic cancer	5.85e-06	0.000148	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—PRKCG—hematologic cancer	5.85e-06	0.000148	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—ADCY7—hematologic cancer	5.84e-06	0.000147	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—NCOA3—hematologic cancer	5.84e-06	0.000147	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—JAK2—hematologic cancer	5.8e-06	0.000146	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—NUP214—hematologic cancer	5.79e-06	0.000146	CbGpPWpGaD
Alfentanil—ALB—Transmembrane transport of small molecules—CREBBP—hematologic cancer	5.77e-06	0.000146	CbGpPWpGaD
Alfentanil—ALB—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	5.75e-06	0.000145	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—ABCG2—hematologic cancer	5.68e-06	0.000143	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—MTR—hematologic cancer	5.68e-06	0.000143	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—CYCS—hematologic cancer	5.63e-06	0.000142	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—HSP90AA1—hematologic cancer	5.59e-06	0.000141	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—MTHFR—hematologic cancer	5.57e-06	0.000141	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—ENO2—hematologic cancer	5.57e-06	0.00014	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—PIK3CB—hematologic cancer	5.51e-06	0.000139	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—IL2RA—hematologic cancer	5.46e-06	0.000138	CbGpPWpGaD
Alfentanil—ALB—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	5.43e-06	0.000137	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—FHL2—hematologic cancer	5.43e-06	0.000137	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—IL2—hematologic cancer	5.42e-06	0.000137	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—TERT—hematologic cancer	5.4e-06	0.000136	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—GSTT1—hematologic cancer	5.4e-06	0.000136	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—AGRN—hematologic cancer	5.32e-06	0.000134	CbGpPWpGaD
Alfentanil—ALB—Platelet activation, signaling and aggregation—AKT1—hematologic cancer	5.32e-06	0.000134	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—SDC1—hematologic cancer	5.28e-06	0.000133	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—PDGFB—hematologic cancer	5.27e-06	0.000133	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	5.24e-06	0.000132	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—TSC2—hematologic cancer	5.15e-06	0.00013	CbGpPWpGaD
Alfentanil—ALB—Metabolism—NQO1—hematologic cancer	5.12e-06	0.000129	CbGpPWpGaD
Alfentanil—ALB—Metabolism—CD44—hematologic cancer	5.12e-06	0.000129	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—IL2—hematologic cancer	5.06e-06	0.000128	CbGpPWpGaD
Alfentanil—ABCB1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	5.06e-06	0.000128	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—HMMR—hematologic cancer	5.05e-06	0.000127	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—IDH2—hematologic cancer	5.05e-06	0.000127	CbGpPWpGaD
Alfentanil—ALB—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	5.02e-06	0.000127	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—GSTP1—hematologic cancer	4.96e-06	0.000125	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—FGFR3—hematologic cancer	4.96e-06	0.000125	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—MAPK14—hematologic cancer	4.91e-06	0.000124	CbGpPWpGaD
Alfentanil—ALB—Metabolism—CYCS—hematologic cancer	4.85e-06	0.000122	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—ESR1—hematologic cancer	4.82e-06	0.000121	CbGpPWpGaD
Alfentanil—ALB—Metabolism—HSP90AA1—hematologic cancer	4.82e-06	0.000121	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—FN1—hematologic cancer	4.76e-06	0.00012	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—ARNTL—hematologic cancer	4.74e-06	0.00012	CbGpPWpGaD
Alfentanil—ABCB1—Transmembrane transport of small molecules—ALB—hematologic cancer	4.73e-06	0.000119	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—BAD—hematologic cancer	4.7e-06	0.000119	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—NFKBIA—hematologic cancer	4.7e-06	0.000119	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—ABCB1—hematologic cancer	4.7e-06	0.000118	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—PIK3CG—hematologic cancer	4.68e-06	0.000118	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—NOTCH1—hematologic cancer	4.66e-06	0.000117	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—CA9—hematologic cancer	4.62e-06	0.000116	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—ACP5—hematologic cancer	4.62e-06	0.000116	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—CD80—hematologic cancer	4.56e-06	0.000115	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—GSTM1—hematologic cancer	4.56e-06	0.000115	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—NCOR1—hematologic cancer	4.56e-06	0.000115	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—NCOR2—hematologic cancer	4.56e-06	0.000115	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—KIT—hematologic cancer	4.55e-06	0.000115	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—PIK3CG—hematologic cancer	4.55e-06	0.000115	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—NRAS—hematologic cancer	4.55e-06	0.000115	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—EP300—hematologic cancer	4.54e-06	0.000115	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—NQO1—hematologic cancer	4.49e-06	0.000113	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—CD44—hematologic cancer	4.49e-06	0.000113	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—PTPN11—hematologic cancer	4.47e-06	0.000113	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—SRC—hematologic cancer	4.41e-06	0.000111	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—MAPK3—hematologic cancer	4.36e-06	0.00011	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—CREBBP—hematologic cancer	4.34e-06	0.00011	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—IDH1—hematologic cancer	4.34e-06	0.000109	CbGpPWpGaD
Alfentanil—ALB—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	4.33e-06	0.000109	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—CREB1—hematologic cancer	4.33e-06	0.000109	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—VEGFA—hematologic cancer	4.3e-06	0.000108	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—TXN—hematologic cancer	4.29e-06	0.000108	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—GSTO1—hematologic cancer	4.29e-06	0.000108	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—ABCC3—hematologic cancer	4.29e-06	0.000108	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—BRAF—hematologic cancer	4.28e-06	0.000108	CbGpPWpGaD
Alfentanil—ALB—Metabolism—GSTP1—hematologic cancer	4.27e-06	0.000108	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—NRAS—hematologic cancer	4.25e-06	0.000107	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—CYCS—hematologic cancer	4.25e-06	0.000107	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—CCL2—hematologic cancer	4.24e-06	0.000107	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—IL6R—hematologic cancer	4.23e-06	0.000107	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—CREBBP—hematologic cancer	4.22e-06	0.000106	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—HSP90AA1—hematologic cancer	4.22e-06	0.000106	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—SPHK1—hematologic cancer	4.2e-06	0.000106	CbGpPWpGaD
Alfentanil—ALB—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	4.13e-06	0.000104	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—PIK3CD—hematologic cancer	4.12e-06	0.000104	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—MAPK3—hematologic cancer	4.07e-06	0.000103	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—ALB—hematologic cancer	4.06e-06	0.000102	CbGpPWpGaD
Alfentanil—ALB—Metabolism—ABCB1—hematologic cancer	4.04e-06	0.000102	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—UGT1A1—hematologic cancer	4.03e-06	0.000102	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—MAP2K1—hematologic cancer	4.03e-06	0.000102	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—MTHFR—hematologic cancer	4.03e-06	0.000102	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—PIK3CD—hematologic cancer	4e-06	0.000101	CbGpPWpGaD
Alfentanil—OPRM1—GPCR downstream signaling—PIK3CA—hematologic cancer	3.96e-06	0.0001	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—TGFB1—hematologic cancer	3.95e-06	9.95e-05	CbGpPWpGaD
Alfentanil—ALB—Metabolism—GSTM1—hematologic cancer	3.93e-06	9.9e-05	CbGpPWpGaD
Alfentanil—ALB—Metabolism—NCOR1—hematologic cancer	3.93e-06	9.9e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—CRABP1—hematologic cancer	3.92e-06	9.9e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—SLC22A1—hematologic cancer	3.92e-06	9.9e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—KRAS—hematologic cancer	3.92e-06	9.88e-05	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—PIK3R1—hematologic cancer	3.89e-06	9.8e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—FGF2—hematologic cancer	3.83e-06	9.67e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—ALOX5—hematologic cancer	3.82e-06	9.65e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—PIK3R1—hematologic cancer	3.78e-06	9.53e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—GSTP1—hematologic cancer	3.74e-06	9.44e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—NUP98—hematologic cancer	3.7e-06	9.34e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—JAK2—hematologic cancer	3.67e-06	9.26e-05	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—KRAS—hematologic cancer	3.66e-06	9.22e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—PIK3CA—hematologic cancer	3.6e-06	9.08e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—ADCY7—hematologic cancer	3.6e-06	9.07e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—NCOA3—hematologic cancer	3.6e-06	9.07e-05	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—PIK3CB—hematologic cancer	3.59e-06	9.05e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—MDM2—hematologic cancer	3.59e-06	9.04e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—NUP214—hematologic cancer	3.57e-06	9.01e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—MTR—hematologic cancer	3.5e-06	8.82e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—ABCG2—hematologic cancer	3.5e-06	8.82e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—PIK3CB—hematologic cancer	3.49e-06	8.8e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—MTOR—hematologic cancer	3.49e-06	8.8e-05	CbGpPWpGaD
Alfentanil—ALB—Metabolism—MTHFR—hematologic cancer	3.47e-06	8.75e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—GSTM1—hematologic cancer	3.44e-06	8.68e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—NCOR1—hematologic cancer	3.44e-06	8.68e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—ENO2—hematologic cancer	3.43e-06	8.65e-05	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—PIK3CG—hematologic cancer	3.38e-06	8.54e-05	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—PIK3CA—hematologic cancer	3.36e-06	8.47e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—HRAS—hematologic cancer	3.33e-06	8.4e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—GSTT1—hematologic cancer	3.33e-06	8.39e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—CDKN1B—hematologic cancer	3.27e-06	8.26e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—SDC1—hematologic cancer	3.25e-06	8.2e-05	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—TP53—hematologic cancer	3.25e-06	8.19e-05	CbGpPWpGaD
Alfentanil—OPRM1—GPCR downstream signaling—AKT1—hematologic cancer	3.24e-06	8.17e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—CASP3—hematologic cancer	3.21e-06	8.09e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—IL2—hematologic cancer	3.2e-06	8.08e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—IL6—hematologic cancer	3.19e-06	8.04e-05	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—CREBBP—hematologic cancer	3.14e-06	7.92e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—CCND1—hematologic cancer	3.12e-06	7.88e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—JUN—hematologic cancer	3.12e-06	7.86e-05	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—HRAS—hematologic cancer	3.11e-06	7.84e-05	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—PTEN—hematologic cancer	3.1e-06	7.82e-05	CbGpPWpGaD
Alfentanil—ALB—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	3.06e-06	7.71e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—MTHFR—hematologic cancer	3.04e-06	7.67e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—CDKN1A—hematologic cancer	3.02e-06	7.62e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—PTEN—hematologic cancer	3.01e-06	7.6e-05	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—PIK3CD—hematologic cancer	2.98e-06	7.51e-05	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—EP300—hematologic cancer	2.96e-06	7.46e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—MAPK8—hematologic cancer	2.95e-06	7.44e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—AKT1—hematologic cancer	2.94e-06	7.42e-05	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—ALB—hematologic cancer	2.94e-06	7.41e-05	CbGpPWpGaD
Alfentanil—ALB—Metabolism—PIK3CG—hematologic cancer	2.91e-06	7.35e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—EP300—hematologic cancer	2.87e-06	7.25e-05	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—PIK3R1—hematologic cancer	2.81e-06	7.09e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—SRC—hematologic cancer	2.8e-06	7.05e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—NQO1—hematologic cancer	2.76e-06	6.97e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—CD44—hematologic cancer	2.76e-06	6.97e-05	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—AKT1—hematologic cancer	2.74e-06	6.92e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—VEGFA—hematologic cancer	2.72e-06	6.87e-05	CbGpPWpGaD
Alfentanil—ALB—Metabolism—CREBBP—hematologic cancer	2.7e-06	6.82e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—STAT3—hematologic cancer	2.7e-06	6.8e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—NRAS—hematologic cancer	2.69e-06	6.78e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—CYCS—hematologic cancer	2.62e-06	6.6e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	2.6e-06	6.56e-05	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—PIK3CB—hematologic cancer	2.59e-06	6.54e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—MAPK3—hematologic cancer	2.58e-06	6.5e-05	CbGpPWpGaD
Alfentanil—ALB—Metabolism—PIK3CD—hematologic cancer	2.56e-06	6.46e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—PIK3CG—hematologic cancer	2.55e-06	6.44e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—MYC—hematologic cancer	2.5e-06	6.32e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—TGFB1—hematologic cancer	2.5e-06	6.3e-05	CbGpPWpGaD
Alfentanil—ALB—Metabolism—PIK3R1—hematologic cancer	2.42e-06	6.1e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—CREBBP—hematologic cancer	2.37e-06	5.97e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—KRAS—hematologic cancer	2.31e-06	5.84e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—GSTP1—hematologic cancer	2.31e-06	5.82e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—PIK3CD—hematologic cancer	2.25e-06	5.66e-05	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—PTEN—hematologic cancer	2.24e-06	5.65e-05	CbGpPWpGaD
Alfentanil—ALB—Metabolism—PIK3CB—hematologic cancer	2.23e-06	5.63e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—ALB—hematologic cancer	2.22e-06	5.59e-05	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—PIK3CA—hematologic cancer	2.19e-06	5.52e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—ABCB1—hematologic cancer	2.18e-06	5.51e-05	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—EP300—hematologic cancer	2.14e-06	5.39e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—PIK3CA—hematologic cancer	2.13e-06	5.36e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—PIK3R1—hematologic cancer	2.12e-06	5.35e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—NCOR1—hematologic cancer	2.12e-06	5.35e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—GSTM1—hematologic cancer	2.12e-06	5.35e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—TP53—hematologic cancer	2.06e-06	5.19e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—HRAS—hematologic cancer	1.97e-06	4.96e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—PIK3CB—hematologic cancer	1.96e-06	4.94e-05	CbGpPWpGaD
Alfentanil—ALB—Metabolism—PTEN—hematologic cancer	1.93e-06	4.87e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—IL6—hematologic cancer	1.88e-06	4.75e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—MTHFR—hematologic cancer	1.87e-06	4.72e-05	CbGpPWpGaD
Alfentanil—ALB—Metabolism—EP300—hematologic cancer	1.84e-06	4.64e-05	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—AKT1—hematologic cancer	1.79e-06	4.51e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—AKT1—hematologic cancer	1.74e-06	4.38e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—PTEN—hematologic cancer	1.69e-06	4.27e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—EP300—hematologic cancer	1.61e-06	4.07e-05	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—PIK3CA—hematologic cancer	1.58e-06	3.99e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—PIK3CG—hematologic cancer	1.57e-06	3.97e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—CREBBP—hematologic cancer	1.46e-06	3.68e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—PIK3CD—hematologic cancer	1.38e-06	3.49e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—ALB—hematologic cancer	1.37e-06	3.44e-05	CbGpPWpGaD
Alfentanil—ALB—Metabolism—PIK3CA—hematologic cancer	1.36e-06	3.43e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—PIK3R1—hematologic cancer	1.31e-06	3.29e-05	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—AKT1—hematologic cancer	1.29e-06	3.26e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—PIK3CB—hematologic cancer	1.21e-06	3.04e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—PIK3CA—hematologic cancer	1.19e-06	3.01e-05	CbGpPWpGaD
Alfentanil—ALB—Metabolism—AKT1—hematologic cancer	1.11e-06	2.81e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—PTEN—hematologic cancer	1.04e-06	2.63e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—EP300—hematologic cancer	9.94e-07	2.51e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—AKT1—hematologic cancer	9.75e-07	2.46e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—PIK3CA—hematologic cancer	7.35e-07	1.85e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—AKT1—hematologic cancer	6e-07	1.51e-05	CbGpPWpGaD
